Clinical Trial Update: Bismuth Based Quadruple Therapy 10 Days in Children [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating a bismuth-based quadruple therapy over 10 days in children for Helicobacter pylori infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• Bismuth-based quadruple therapy

Snippet

Sponsor: Queen Fabiola Children's University Hospital | Conditions: Helicobacter Pylori Infection | Phase 4 | Status: UNKNOWN